Select Publications
Journal articles
2006, 'Evaluation of pituitary function in the fatigued patient: a review of 59 cases', European Journal of Endocrinology, 154, pp. 147 - 157
,2006, 'Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget`s disease', Clinical Laboratory, 52, pp. 1 - 10
,2006, 'Suppression of HPA axis in adults taking inhaled corticosteroids', Thorax, 61, pp. 272 - 273
,2005, 'Serum cathepsin K levels reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget`s disease', Bone, 36, pp. S139 - S140, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229979900081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2005, 'Beneficial postprandial effect of a small amount of alcohol on diabetesand cardiovascular risk factors: Modification by insulin resistance', Journal of Clinical Endocrinology and Metabolism, 90, pp. 661 - 672
,2004, 'Thiazolidinediones (multiple letters) [2]', Australian Prescriber, 27, pp. 139
,2004, 'Thiazolidinediones - Mechanisms of action', Australian Prescriber, 27, http://dx.doi.org/10.18773/austprescr.2004.059
,2004, 'Do gene-environment interactions influence fasting plasma lipids? Astudy of twins', European Journal of Clinical Investigation, 34, pp. 590 - 598
,2004, 'Inflammation, Insulin Resistance, and Adiposity: A study of first-degree relatives of type 2 diabetic subjects', Diabetes Care, 27, pp. 2033 - 2040, http://www.sciencedirect.com/science/article/B6WVB-4D3R5H1-4MT/2/20d5cadafd9bbe5b03e2de182024dee9
,2004, 'Insulin resistance and obesity', Clinics in Dermatology, 22, pp. 289 - 295, http://www.sciencedirect.com/science/article/B6T5G-4DGM0SS-4/2/fa6d5607668192a07aee4cc239ed4eb2
,2004, 'Obesity is an important determinant of baseline serum C-reactiveprotein concentration in monozygotic twins, independent of geneticinfluences', Circulation, 109, pp. 3022 - 3028
,2003, 'Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: Is abdominal adiposity the mediator?', Diabetes Care, 26, pp. 2734 - 2740, http://dx.doi.org/10.2337/diacare.26.10.2734
,2003, 'Type 1 diabetes is not associated with increased central abdominal obesity - Response to Sobel', DIABETES CARE, 26, pp. 2703 - 2703, http://dx.doi.org/10.2337/diacare.26.9.2703
,2003, 'Moderate Alcohol Consumption and oestrogen replacement are associated with insulin sensitivity: is lower abdominal adiposity the mediator?', Diabetes Care, 26, pp. 2734 - 2740
,2003, 'Moderate Alcohol Consumption, Dietary Fat Composition, and Abdominal Obesity in Women: Evidence of Gene-Environment Interaction', Journal of Clinical Endocrinology and Metabolism, 88, pp. 5381 - 5386
,2003, 'Physical activity reduces genetic susceptibility to increased central systolic pressure augmentation: a study of female twins', Journal of the American College of Cardiology, 42, pp. 264 - 270
,2003, 'Type I diabetes is not associated with increased central abdominal obesity', Diabetes Care, 26, pp. 2703 - 2703
,2002, 'ANCA-positive vasculitis induced by thioridazine: Confirmed by rechallenge [2]', British Journal of Dermatology, 147, pp. 1265 - 1267, http://dx.doi.org/10.1046/j.1365-2133.2002.05000_2.x
,2002, 'Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus', Journal of Clinical Endocrinology and Metabolism, 87, pp. 1036 - 1040, http://dx.doi.org/10.1210/jcem.87.3.8324
,2002, 'Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomography', Obesity Research, 10, pp. 260 - 265, http://dx.doi.org/10.1038/oby.2002.35
,2002, 'Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus.', J Clin Endocrinol Metab, 87, pp. 1036 - 1040, http://dx.doi.org/10.1210/jcem.87.3.8324
,2001, '`Adrenal apoplexy: an inconspicuous cause of hypotension in the intensive care patient.` Clinical review', Medical Journal of Australia, 175, pp. 384 - 385
,2001, 'Treatment of an Atraumatic Fracture: The importance of establishing a definitive diagnosis.', Journal of Bone and Mineral Research, 16, pp. 2362 - 2364
,2000, 'Clinical trials and clinical practice - Bridging the gaps in type 2 diabetes: An evidence-based approach to risk factor modification in type 2 diabetes', Australian and New Zealand Journal of Medicine, 30, pp. 483 - 491, http://dx.doi.org/10.1111/j.1445-5994.2000.tb02056.x
,Conference Papers
2022, 'Su1261: PANCREATIC CANCER-RELATED DIABETES: A HIGH FRUCTOSE DIET FED TO TRANSGENIC, KRASLSL-G12D/+; PDXCRE/+ (KC) MICE, IS ASSOCIATED WITH PANCREATIC STELLATE CELL ACTIVATION AND ACCELERATED CANCER PROGRESSION', in Gastroenterology, Elsevier BV, http://dx.doi.org/10.1016/s0016-5085(22)61328-3
,2020, 'Pancreatic cancer-related diabetes: Do pancreatic stellate cell and cancer cell derived exosomes play a role?', in Pancreratology, presented at European Pancreatic Club
,2020, 'I. Pancreatic Stellate Cell and Cancer Cell Derived Exosomes Impair Beta Cell Function: Implications for Pancreatic Cancer Related Diabetes', in Gastroenterology, Elsevier, Chicago, USA, presented at Digestive Disease Week, Chicago, USA, 02 May 2020, http://dx.doi.org/10.1016/S0016-5085(20)31245-2
,2020, 'PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, TX, Austin, pp. S221 - S221, presented at Crohn's and Colitis Congress, TX, Austin, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000540349500565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Dual Insulin Resistance in Muscle and Liver, but Not a Single Site, Is Associated with Visceral and Liver Lipid Accumulation in Obesity', in Clinical Studies in Obesity: Endocrine Society, USA, presented at Endo, USA, 21 June 2014 - 24 June 2014
,2010, 'Short-Term Overfeeding and Moderate Weight Gain Induces Peripheral Insulin Resistance and Increases Systemic Oxidative Stress in Healthy Humans', in DIABETES, AMER DIABETES ASSOC, FL, Orlando, pp. A422 - A422, presented at 70th Annual Meeting of the American-Diabetes-Association, FL, Orlando, 25 June 2010 - 29 June 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000278844602211&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Brown Adipose Tissue in Humans: Prevalence, Anthropometric and Metabolic Predictors.', in ENDOCRINE REVIEWS, ENDOCRINE SOC, CA, San Diego, presented at 92nd Meeting and Expo of the Endocrine Society (ENDO 2010), CA, San Diego, 19 June 2010 - 22 June 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281989401426&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Cellular Characterisation of Human Brown Adipose Tissue Identified by Positron Emission Tomography.', in ENDOCRINE REVIEWS, ENDOCRINE SOC, CA, San Diego, presented at 92nd Meeting and Expo of the Endocrine Society (ENDO 2010), CA, San Diego, 19 June 2010 - 22 June 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281989402473&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Experimental weight gain in humans induces insulin resistance in absence of systemic or adipose tissue inflammation', in DIABETOLOGIA, SPRINGER, AUSTRIA, Vienna, pp. S74 - S74, presented at 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, AUSTRIA, Vienna, 30 September 2009 - 02 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269262400165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Experimental weight gain in humans induces insulin resistance in absence of systemic or adipose tissue inflammation', in Diabetologia, Springer, New York, NY, USA, pp. 164 - 165, presented at Diabetologia
,2003, 'Gene-environment interactions influence relationships between alcohol and polyunsaturated fat intakes and central abdominal fat in healthy female twins.', in DIABETOLOGIA, SPRINGER-VERLAG, FRANCE, PARIS, pp. A227 - A227, presented at 18th Congress of the International-Diabetes-Federation, FRANCE, PARIS, 24 August 2003 - 29 August 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000185242100655&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Posters
2022, 'The trends and opinions of Australian clinicians on the use of antihyperglycemic agents in heart failure patients', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2022 - 29 November 2019
,2017, 'The Safety and Pharmacokinetics of Metformin in Heart Failure', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'The Safety of Metformin in Haemodiafiltration', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,Conference Presentations
2017, 'The safety and pharmacokinetics of metformin in heart failure', presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'The Safety of Metformin in Haemodiafiltration', presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2016, 'Extraction of Metformin During Haemodiafiltration', presented at ASCEPT-MPGPCR, Melbourne, 27 November 2016 - 30 November 2016
,2013, 'Sugar-sweetened beverages, genetic risk, and obesity [1]', http://dx.doi.org/10.1056/NEJMc1213563
,Conference Abstracts
2023, 'Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues', in Trends in the use of Cardiometabolic Medicines in Australia (2014-2022): Sodium-glucose Co-transporter 2 Inhibitors and Glucagon-like Peptide-1 Analogues, presented at Australian Diabetes Congress 2023
,2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)', in Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022), presented at 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2023
,2022, 'PRESCRIPTION OF SGLT2 INHIBITORS TO PATIENTS WITH CHRONIC KIDNEY DISEASE: A QUALITATIVE STUDY OF NEPHROLOGISTS AND CARDIOLOGISTS', in NEPHROLOGY, WILEY, Vol. 27, pp. 74 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000864433100145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Insulin resistance and visceral or ectopic fat deposition may independently determine metabolic and cardiovascular complications in type 1 diabetes', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, Vol. 65, pp. S83 - S83, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000841795900160&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Impaired glucose tolerance in transgenic KC mice is associated with pancreatic stellate cell activation and accelerated pancreatic cancer progression', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 32 - 32
,2022, 'PANCREATIC CANCER-RELATED DIABETES: A HIGH FRUCTOSE DIET FED TO TRANSGENIC, KRAS(LSL-G12D/+); PDXCRE/+ (KC) MICE, IS ASSOCIATED WITH PANCREATIC STELLATE CELL ACTIVATION AND ACCELERATED CANCER PROGRESSION', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 162, pp. S562 - S563, presented at Digestive Disease Week (DDW), CA, San Diego, 21 May 2022 - 24 May 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000826446202162&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Effects of pancreatic stellate cell- and cancer cell-derived exosomes on islet cell functions: Implications for pancreatic cancer-related diabetes', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'FRACTURE IN TYPE 2 DIABETES CONFERS EXCESS MORTALITY', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Sydney, Vol. 30, pp. S92 - S92, presented at IOF-Regional 7th Asia-Pacific Osteoporosis Conference, AUSTRALIA, Sydney, 29 November 2018 - 01 December 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469495000151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,